Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,177 | -25,159 | -23,953 | -27,168 | -28,688 |
| Depreciation Amortization | 1,463 | 1,379 | 1,469 | 2,014 | 2,090 |
| Accounts receivable | -1,211 | 2,621 | -1,850 | -2,849 | 815 |
| Other Working Capital | -350 | 2,933 | -2,825 | -358 | 1,395 |
| Other Operating Activity | 17,066 | 9,426 | 14,819 | 3,684 | 3,774 |
| Operating Cash Flow | $-15,209 | $-8,800 | $-12,340 | $-24,677 | $-20,613 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7 | 111 | -11 | 12,703 | -534 |
| PPE Investments | -832 | -931 | -369 | -1,270 | -767 |
| Net Acquisitions | N/A | N/A | -11 | N/A | N/A |
| Purchase Sale Intangibles | -1,122 | -1,063 | -848 | -857 | -687 |
| Other Investing Activity | -1,122 | -1,063 | -848 | -857 | -687 |
| Investing Cash Flow | $-1,961 | $-1,883 | $-1,239 | $10,576 | $-1,988 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -77 | -74 | -113 | N/A | N/A |
| Common Stock Issued | 2,561 | 47,840 | 81 | 18,745 | 8,163 |
| Financing Cash Flow | $2,484 | $47,766 | $-32 | $18,745 | $8,163 |
| Beginning Cash Position | 48,275 | 11,192 | 24,803 | 20,159 | 34,598 |
| End Cash Position | 33,589 | 48,275 | 11,192 | 24,803 | 20,159 |
| Net Cash Flow | $-14,686 | $37,083 | $-13,611 | $4,644 | $-14,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,209 | -8,800 | -12,340 | -24,677 | -20,613 |
| Capital Expenditure | -832 | -931 | -369 | -1,270 | -767 |
| Free Cash Flow | -16,041 | -9,731 | -12,709 | -25,947 | -21,381 |